SBT Flashcards
What is the archetypal NSAID? (1)
Aspirin
What are three characteristics of NSAIDs? (3)
Analgesic
Anti-pyretic
Anti-inflammatory
What are NSAIDs used to treat? (4)
Low grade pain (chronic inflamm. e.g. arthritis)
Bone pain (cancer metastases)
Fever (associated with infections)
Inflammation (to decrease symptoms e.g. oedema, redness, itch)
What is the mechanism of the main therapeutic action of NSAIDS? (1)
Inhibition of COX
What does the COX enzyme do? (2)
Converts arachidonic acid to prostaglandins + thromboxanes
Inhibition of COX -2 therefore reduces PG/TX inflammatory agents
Where is COX-1 present? (2)
In platelets
Constitutively active
What can COX-2 be induced by? (2)
IL-1β + TNFα etc.
Do NSAIDs act reversibly or irreversibly on COX? (3)
Aspirin acts irreversibly
Others act reversibly
Significant in prophylactic use in CV disease
Why is paracetamol a special case? (6)
Not an NSAID
Analgesic with anti-inflamm. effects
Little inhibiton of COX-1/-2 in peripheral tissues
Weakly inhibits COX-3 in CNS
May modulate serotonergic transmission
May inhibit COX-mediated generation of hydroxypeptdies (which stimulate COX activity) from AA metabolism
What are examples of other NSAIDs? (5)
Etodolac Meloxicam Ibuprofen Naproxen Indomethacin etc.
How do IL-1 and PGE2 cause fever? (5)
Bacterial endotoxins produced during infections stimulate macrophages to release IL-1
IL-1β acts on hypothalamus to cause PGE2 release (via COX-2)
Increased PGE2 depresses temp-sensitive neurones
PGE2 elevates set point temp
Onset of fever
How do NSAIDs have an antipyretic action? (4)
NSAIDs block PGE2 production
Set point is lowered to normal level
Fever dissipates
NSAIDs have no effect on normal body temp
Why are NSAIDs required for analgesia? (4)
PGs sensitise + stimulate nociceptors
Oedema produced by inflamm. also directly activates nociceptive nerve fibres
PGs interact synergistically with other pain producing substances (kinin, 5-HT, histamines)
To produce hyperalgesia (increased sensitivity to pain)
How do NSAIDs have an analgesic action? (5)
Block PG production (which breaks cycle -> pain relief
Useful for pain associated with production of inflamm agents (PGs/TXs)
Such as arthritis, toothache, headache)
NSAIDs block PG-mediated vasodilation
COX-1, COX-3, COX-3 inhibition in CNS
How do PGE2 + PGI2 have powerful acute inflammatory effects? (3)
Arteriolar dilation (increased blood flow) Increase permeability in post-capillary venules Both processes increase influx of inflamm. mediators into interstitial space
How do NSAIDs have an anti-inflammatory action? ()
Inhibition of PGE2/PGI2 reduces redness + swelling
Only provide symptomatic relief
They do not cure underlying cause of inflammation (e.g. in arthritis help but do not cure)
Decreased COX-2-generated PGs (effects develop gradually)
What role does thromboxane A2 have in vascular haemostasis? (2)
Platelet aggregation
Vasoconstriction
What effect to NSAIDs have on TXA2 levels? (2)
Decrease levels
So increase bleeding time
Could be problematic in childbirth/surgery
What is an example of aspirin being used prophylactically? (1)
In disease where platelet aggregation is increased
How can PGs contribute to arthritis? (5)
PGs with acute inflamm. effects contribute to swelling + pain
Arteriolar dilation
Increased microvascular permeability
Hyperalgesia
Thus NSAIDs diminish effects but do not treat cause
How do PGs protect gastric mucosa? (2)
PGE2/I2 stimulate mucus secretion
+ inhibit gastric acid secretion
+ promote blood flow
Cytoprotective mechanisms
What are the most common adverse reactions to older NSAIDs? (3)
Gastric SEs
NSAIDs decrease cytoprotective mechanisms of PGs
Bleeding + ulceration can result
Why might COX-2 selective inhibitors be ‘gastric-friendly’? (1)
Suggested that COX-1 is expressed in gut
What other effects can NSAIDs have in GI tract? (8)
NSAIDs = acidic Decreased mucus production Decreased HCO3- Increased acid production Increased leukotriene production Increased blood loss Interfere with tissue healing (COX-2 inhibition) Nausea, dyspepsia (indigestion) + GI contraction (COX-1 inhibition)